Other Species / Isoforms
  CCDC61 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K57-ub
FIEDLTHkTGNFKQF
0 1
CCDC61 (human) FIEDLTHkTGNFKQF K57-ub
CCDC61 (mouse) FIEDLTHKTGNFKQF K57
CCDC61 (rat) FIEDLTHKTGNFKQF K57
Y89-p
VTLDLLTyTDLESLR
0 1
CCDC61 (human) VTLDLLTyTDLESLR Y89-p
CCDC61 (mouse) VTLDLLTYTDLESLR Y89
CCDC61 (rat) VTLDLLTYTDLESLR Y89
R98-m1
DLESLRNrkMGGrPG
0 1
CCDC61 (human) DLESLRNrkMGGrPG R98-m1
CCDC61 (mouse) DLESLRSRKLGGRPG R98
CCDC61 (rat) DLESLRSRKLGGRPG R98
K99-ub
LESLRNrkMGGrPGs
0 1
CCDC61 (human) LESLRNrkMGGrPGs K99-ub
CCDC61 (mouse) LESLRSRKLGGRPGA K99
CCDC61 (rat) LESLRSRKLGGRPGP K99
R103-m1
RNrkMGGrPGsLAPR
0 1
CCDC61 (human) RNrkMGGrPGsLAPR R103-m1
CCDC61 (mouse) RSRKLGGRPGALAPR R103
CCDC61 (rat) RSRKLGGRPGPCPRS R103
S106-p
kMGGrPGsLAPRSAQ
0 2
CCDC61 (human) kMGGrPGsLAPRSAQ S106-p
CCDC61 (mouse) KLGGRPGALAPRSAQ A106
CCDC61 (rat) KLGGRPGPCPRSAQL P106
Y119
AQLNSKRYLILIYSV
0 1
CCDC61 (human) AQLNSKRYLILIYSV Y119
CCDC61 (mouse) AQLNSKRyLILIysV Y119-p
CCDC61 (rat) AQLNSKRYLILIYSV Y118
Y124
KRYLILIYSVEFDRI
0 1
CCDC61 (human) KRYLILIYSVEFDRI Y124
CCDC61 (mouse) KRyLILIysVEFDRI Y124-p
CCDC61 (rat) KRYLILIYSVEFDRI Y123
S125
RYLILIYSVEFDRIH
0 1
CCDC61 (human) RYLILIYSVEFDRIH S125
CCDC61 (mouse) RyLILIysVEFDRIH S125-p
CCDC61 (rat) RYLILIYSVEFDRIH S124
Y133
VEFDRIHYPLPLPYQ
0 1
CCDC61 (human) VEFDRIHYPLPLPYQ Y133
CCDC61 (mouse) VEFDRIHyPLPLPyQ Y133-p
CCDC61 (rat) VEFDRIHYPLPLPYQ Y132
Y139
HYPLPLPYQGKPDPV
0 1
CCDC61 (human) HYPLPLPYQGKPDPV Y139
CCDC61 (mouse) HyPLPLPyQGKPDPV Y139-p
CCDC61 (rat) HYPLPLPYQGKPDPV Y138
K156-ub
QGIIRSLkEELGRLQ
0 1
CCDC61 (human) QGIIRSLkEELGRLQ K156-ub
CCDC61 (mouse) QGIIRSLKEELGHLR K156
CCDC61 (rat) QGIIRSLKEELGHLR K155
T170-p
QGLDGQNtRDTRENE
0 2
CCDC61 (human) QGLDGQNtRDTRENE T170-p
CCDC61 (mouse) gap -
CCDC61 (rat) gap -
K253-ub
QDCRRLAkELEEAKA
0 1
CCDC61 (human) QDCRRLAkELEEAKA K253-ub
CCDC61 (mouse) QDSRRLAKELEEVKA K251
CCDC61 (rat) QDCRRLAKELEEVKA K250
S261-p
ELEEAKAsERSLRAR
0 3
CCDC61 (human) ELEEAKAsERSLRAR S261-p
CCDC61 (mouse) ELEEVKASERNLRAR S259
CCDC61 (rat) ELEEVKASERNLRAR S258
K270-ub
RSLRARLkTLTSELA
0 1
CCDC61 (human) RSLRARLkTLTSELA K270-ub
CCDC61 (mouse) RNLRARLKTLNSELA K268
CCDC61 (rat) RNLRARLKTLNCELA K267
Y279
LTSELALYKRGRRtP
0 1
CCDC61 (human) LTSELALYKRGRRtP Y279
CCDC61 (mouse) LNSELAMyRRGRRTL Y277-p
CCDC61 (rat) LNCELAMYRRGRRTL Y276
T285-p
LYKRGRRtPPVQPPP
0 3
CCDC61 (human) LYKRGRRtPPVQPPP T285-p
CCDC61 (mouse) MyRRGRRTLPPVAVR T283
CCDC61 (rat) MYRRGRRTLPAGARE T282
S334-p
RGRPARPsPsPtGGR
Upstream
0 17
Treatment
  • dasatinib
  • MG132_withdrawal
CCDC61 (human) RGRPARPsPsPtGGR S334-p
CCDC61 (mouse) RGRPAHPsPsPTGSR S330-p
CCDC61 (rat) HGRPAHPSPSPTGSR S328
S336-p
RPARPsPsPtGGRAL
Upstream
0 16
Treatment
  • MG132_withdrawal
CCDC61 (human) RPARPsPsPtGGRAL S336-p
CCDC61 (mouse) RPAHPsPsPTGSRAP S332-p
CCDC61 (rat) RPAHPSPSPTGSRVP S330
T338-p
ARPsPsPtGGRALRF
Upstream
0 4
Treatment
  • dasatinib
  • MG132_withdrawal
CCDC61 (human) ARPsPsPtGGRALRF T338-p
CCDC61 (mouse) AHPsPsPTGSRAPRF T334
CCDC61 (rat) AHPSPSPTGSRVPRF T332
K352-ac
FDPTAFVkAkERkQR
0 1
CCDC61 (human) FDPTAFVkAkERkQR K352-ac
CCDC61 (mouse) FDPTAFVKAKEKKQR K348
CCDC61 (rat) FDPTAFVKAKEKKQR K346
K354-ac
PTAFVkAkERkQREI
0 1
CCDC61 (human) PTAFVkAkERkQREI K354-ac
CCDC61 (mouse) PTAFVKAKEKKQREI K350
CCDC61 (rat) PTAFVKAKEKKQREI K348
K357-ac
FVkAkERkQREIQMk
0 1
CCDC61 (human) FVkAkERkQREIQMk K357-ac
CCDC61 (mouse) FVKAKEKKQREIRMK K353
CCDC61 (rat) FVKAKEKKQREIRMK K351
K364-ub
kQREIQMkQQQRNRL
0 1
CCDC61 (human) kQREIQMkQQQRNRL K364-ub
CCDC61 (mouse) KQREIRMKQQQQQRN K360
CCDC61 (rat) KQREIRMKRQQQQQQ K358
S373-p
QQRNRLGsGGsGDGP
Upstream
0 222
Treatment
  • dasatinib
  • EGF
  • lapatinib
  • selumetinib
  • vemurafenib
view more >
CCDC61 (human) QQRNRLGsGGsGDGP S373-p
CCDC61 (mouse) QQRNRMGsGGsGDGP S371-p
CCDC61 (rat) QQRNRMGsGGsGDGP S372-p
S376-p
NRLGsGGsGDGPsVs
Upstream
0 200
Treatment
  • dasatinib
  • EGF
  • ischemia
  • selumetinib
  • vemurafenib
view more >
CCDC61 (human) NRLGsGGsGDGPsVs S376-p
CCDC61 (mouse) NRMGsGGsGDGPsVS S374-p
CCDC61 (rat) NRMGsGGsGDGPSVS S375-p
S381-p
GGsGDGPsVsWSRQT
0 9
CCDC61 (human) GGsGDGPsVsWSRQT S381-p
CCDC61 (mouse) GGsGDGPsVSWSQQT S379-p
CCDC61 (rat) GGsGDGPSVSWSHQT S380
S383-p
sGDGPsVsWSRQTQP
0 1
CCDC61 (human) sGDGPsVsWSRQTQP S383-p
CCDC61 (mouse) sGDGPsVSWSQQTRP S381
CCDC61 (rat) sGDGPSVSWSHQTRP S382
S408
PNRSRNRSSSVDSFR
0 1
CCDC61 (human) PNRSRNRSSSVDSFR S408
CCDC61 (mouse) VNRSRNRsssVDsFR S406-p
CCDC61 (rat) ANRSRNRSSSVDSFR S407
S409
NRSRNRSSSVDSFRs
0 1
CCDC61 (human) NRSRNRSSSVDSFRs S409
CCDC61 (mouse) NRSRNRsssVDsFRS S407-p
CCDC61 (rat) NRSRNRSSSVDSFRS S408
S410
RSRNRSSSVDSFRsR
0 1
CCDC61 (human) RSRNRSSSVDSFRsR S410
CCDC61 (mouse) RSRNRsssVDsFRSR S408-p
CCDC61 (rat) RSRNRSSSVDSFRSR S409
S413
NRSSSVDSFRsRCSS
0 1
CCDC61 (human) NRSSSVDSFRsRCSS S413
CCDC61 (mouse) NRsssVDsFRSRCSS S411-p
CCDC61 (rat) NRSSSVDSFRSRCSS S412
S416-p
SSVDSFRsRCSSASs
0 1
CCDC61 (human) SSVDSFRsRCSSASs S416-p
CCDC61 (mouse) ssVDsFRSRCSSVSS S414
CCDC61 (rat) SSVDSFRSRCSSVSS S415
S423-p
sRCSSASsCsDLEDF
0 2
CCDC61 (human) sRCSSASsCsDLEDF S423-p
CCDC61 (mouse) SRCSSVSSCSELEDF S421
CCDC61 (rat) SRCSSVSSCSELEDF S422
S425-p
CSSASsCsDLEDFSE
0 2
CCDC61 (human) CSSASsCsDLEDFSE S425-p
CCDC61 (mouse) CSSVSSCSELEDFSH S423
CCDC61 (rat) CSSVSSCSELEDFSQ S424
S447-p
RRRGKPPsPtPWsGs
0 71
CCDC61 (human) RRRGKPPsPtPWsGs S447-p
CCDC61 (mouse) RGRGKPPsPtPWSRS S446-p
CCDC61 (rat) RGRGKPPSPIPWSGS S447
T449-p
RGKPPsPtPWsGsNM
0 5
CCDC61 (human) RGKPPsPtPWsGsNM T449-p
CCDC61 (mouse) RGKPPsPtPWSRSKT T448-p
CCDC61 (rat) RGKPPSPIPWSGSKT I449
S452-p
PPsPtPWsGsNMKsP
0 1
CCDC61 (human) PPsPtPWsGsNMKsP S452-p
CCDC61 (mouse) PPsPtPWSRSKTkST S451
CCDC61 (rat) PPSPIPWSGSKTKST S452
S454-p
sPtPWsGsNMKsPPV
0 1
CCDC61 (human) sPtPWsGsNMKsPPV S454-p
CCDC61 (mouse) sPtPWSRSKTkSTTQ S453
CCDC61 (rat) SPIPWSGSKTKSTTR S454
K457
PWsGsNMKsPPVERS
0 1
CCDC61 (human) PWsGsNMKsPPVERS K457
CCDC61 (mouse) PWSRSKTkSTTQERS K456-ac
CCDC61 (rat) PWSGSKTKSTTRERN K457
S458-p
WsGsNMKsPPVERSH
0 18
CCDC61 (human) WsGsNMKsPPVERSH S458-p
CCDC61 (mouse) WSRSKTkSTTQERSD S457
CCDC61 (rat) WSGSKTKSTTRERNN S458
K468-ub
VERSHHQksLANsGG
0 1
CCDC61 (human) VERSHHQksLANsGG K468-ub
CCDC61 (mouse) QERSDHQRHLASSGG R467
CCDC61 (rat) RERNNHQRHLASSGA R468
S469-p
ERSHHQksLANsGGW
0 2
CCDC61 (human) ERSHHQksLANsGGW S469-p
CCDC61 (mouse) ERSDHQRHLASSGGW H468
CCDC61 (rat) ERNNHQRHLASSGAW H469
S473-p
HQksLANsGGWVPIK
Upstream
0 7
Treatment
  • ischemia
CCDC61 (human) HQksLANsGGWVPIK S473-p
CCDC61 (mouse) HQRHLASSGGWVPIK S472
CCDC61 (rat) HQRHLASSGAWVPIK S473
K499-ub
AEIDARLkALQEYMN
0 2
CCDC61 (human) AEIDARLkALQEYMN K499-ub
CCDC61 (mouse) AEIDARLKALQEYMN K498
CCDC61 (rat) AEIDARLKALQEYMN K499